MMP9 and myeloid sarcoma: Based on their ability to degenerate basal lamina components and their involvement in damage to the blood–brain barrier (BBB), the role of MMPs, especially MMP-9 and MMP-2, has been widely studied in the brain tissue, serum, and cerebrospinal fluid of MS patients [82].